Descripción del proyecto
Una puntuación de riesgo de cáncer gástrico basada en inteligencia artificial
La inteligencia artificial (IA) se está introduciendo poco a poco en la atención sanitaria para mejorar la evaluación del riesgo de enfermedad y predecir los resultados clínicos o terapéuticos. El equipo del proyecto AIDA, financiado con fondos europeos, pretende generar una puntuación de riesgo basada en IA para el cáncer gástrico, enfermedad que suele detectarse en una fase avanzada, cuando ya poco puede hacerse en términos de tratamiento. Los investigadores combinarán datos de diversas fuentes para detectar la inflamación gástrica precancerosa y generar una puntuación de riesgo de cáncer gástrico. Este método permitirá comprender mejor cómo evoluciona la inflamación gástrica hasta convertirse en cáncer y ayudará a los médicos a formular un plan de tratamiento personalizado para evitar el cáncer gástrico.
Objetivo
Most cases of gastric cancer (GC) are detected at a late stage, when patients have a median life expectancy of about a year. Diagnosing people at risk of developing GC at the pre-symptomatic stage, typically chronic gastric inflammation, could significantly improve the outlook.
Artificial intelligence (AI) can help clinicians make sense of their own data by automating much of the treatment and analysis, which require manual work and years of experience. But it can do more: it can bring together available data from various sources into a vast data lake and cross-correlate the data to derive a ‘risk score’ for gastric cancer and shed light on the mechanisms of its evolution.
Aida aims to do just that. It helps researchers understand the mechanisms that trigger gastric oncogenesis, helps clinicians diagnose precancerous inflammation at the earliest possible stage, suggests personalised therapeutic strategies for treatment and follow-up, and makes personalised recommendations for monitoring patient health status, thus contributing to gastric cancer prevention.
This places Aida squarely on Europe’s agenda of ‘Staying healthy in a rapidly changing society’. Aida unites some of Europe’s leading authorities in the field of gastric inflammation, gastric cancer, leading AI and machine learning experts, experts on data governance and privacy, representatives of the public administration and patient advocates. Aida also has strong ties with the industry.
After the project, the results will live on in a foundation that acts as a transnational focal point for chronic gastric inflammation — and GC in general. We hope that the solid, inclusive design principles of Aida, its societal relevance and its durability will spawn a vigorous ecosystem around chronic gastric inflammation, its understanding and its treatment. And we hope that it will inspire other data collaboratives in health — for other chronic inflammations, other forms of cancer or other ailments altogether.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaRégimen de financiación
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinador
46010 Valencia
España